Wednesday, August 20, 2008 Free Registration Log-in to View Profiles
Empire Relations Group is a Premier Investor Relations Organization representing publicly-traded companies in their communications programs with existing shareholders and potential investors.
investments
OTCBB
OTCBB
Pressroom 
 
 Archived
 
 Non-Public Companies
 Consumer
 Energy, Environment & Natural Resources
 Financials
 Healthcare/BioTech
 Industrials
 IT & Computers
 Materials
 Telecommunications
 Utilities
 
 Public Companies
 Consumer
 Energy, Environment & Natural Resources
 Financials
 Healthcare/BioTech
 Industrials
 IT & Computers
 Materials
 Telecommunications
 Utilities
Search


Non-Public Companies : Healthcare/BioTech


Volunteers Needed for Emphysema Study

Jul 30, 2008 - 9:36:01 AM

News Source MARKET WIRE

Email this article
 Printer friendly page
IOWA CITY, IA -- (MARKET WIRE) -- 07/30/08 -- Volunteers are being recruited for theresearch study of a new investigational procedure that could help relieveshortness of breath and other symptoms for people with severe emphysema.

Called airway bypass, this minimally invasive procedure creates newopenings in the airway wall connecting the damaged lung tissue to thenatural airway. These pathways are supported and kept open by Exhale®Drug-Eluting Stents. The goal is to give air that is trapped in the lungsa way to escape, enabling the person to breathe easier.

The bronchoscopic procedure is being tested by lung experts at Universityof Iowa Hospitals and Clinics and other sites internationally, as part ofthe Exhale Airway Stents for Emphysema (EASE) Trial.

University of Iowa Hospitals and Clinics is currently recruiting patientsfor the EASE Trial. Involvement in the study will last from approximately15 months up to 5 years (depending on if the patient is randomized to thecontrol or the treatment group) and include 8 to 16 physician appointments.All study-related medical procedures will be carried out at no charge tothe patient. Patients will be closely monitored throughout the trial.Participants will also receive at least 14 weeks of pulmonaryrehabilitation therapy.

If you or someone you know over the age of 35 has been diagnosed withadvanced widespread emphysema and no longer smoke (or would be willing tostop smoking two months prior to the study), you may qualify to participatein this study. For more information please call 866-431-3273 or visitwww.EASEtrialUS.com.



Top of Page | Main News Index | EmpireRelations.com Home Page EmpireRelations.com Selected Clients News

Come see our services. Copr. © 2005 Empire Relations Group, Inc.

Healthcare/BioTech
Latest Headlines
Qualia Clinical Services Strengthens Financial Team
Boston Medical Center Uses Envox 7 to Pioneer a New Healthcare Delivery Model
NCSBN Inducted Its Second Group of Fellows of the NCSBN Regulatory Excellence Institute on Aug. 6, 2008, During Its Annual Meeting and Delegate Assembly
Live at Millennium Monument Park -- 2008 Olympic Athletes: Bringing a New Vision to Competition
Wolf Greenfield Wins Three More Years of Patent Protection for Shire Pharmaceuticals' ELAPRASE
New Study Finds Parents Embrace Alternative Treatments for Children's Asthma
Cutting Edge Information's Research Shows Market for Breast Cancer Drugs to Top $40 Billion by 2012
SPEEDEL SHAREHOLDERS ELECT FOUR NOVARTIS OFFICERS AS NEW MEMBERS TO THE BOARD OF DIRECTORS
Government of Canada Contributes $18-Million in Support of Red Cross Relief Efforts in China and Myanmar
TOPIGEN Pharmaceuticals Appoints Mark Parry-Billings, Ph.D., as Chief Executive Officer